Mats Någård
- Prediction of human lung PK for AZD7624, an inhaled P38 inhibitor for the treatment of COPDBy Sara Asimus, Mats Någård, Rikard Pehrson, Tove Hegelund, Paul Jansson and Naimish PatelSara Asimus3Quantitative Clinical Pharmacology, AstraZeneca R&D, Mölndal, SwedenMats Någård1Quantitative Clinical Pharmacology, AstraZeneca R&D, Gaithersburg, MD United StatesRikard Pehrson2RIA iMed DMPK, AstraZeneca R&D, Mölndal, SwedenTove Hegelund2RIA iMed DMPK, AstraZeneca R&D, Mölndal, SwedenPaul Jansson4iMed Respiratory/Inflammation, AstraZeneca R&D, Mölndal, SwedenNaimish Patel5Early Clinical Development, AstraZeneca R&D, Waltham, MA United States
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.